H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 151,950. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Pasadena clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Pasadena storefront.
Skin Substitute Therapy Products in Pasadena, TX for clinics & physicians. Skin substitute therapy for com… Compliance support & pricing — contact Hawk Medical.
32.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Population 151,950. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JH documentation are ready before the first application of skin substitute therapy.
National Skin Substitute Therapy Products notes (how the product actually works)Three grains, kept separate on purpose. City: Census 151,950 and CDC PLACES crude rates. State: Texas DSHS, Diabetes Belt counties present. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the skin substitute therapy account.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 39.1%; arthritis is 20.1%. That is place-level BRFSS modeling, not a clinic census and not a Pasadena trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Pasadena.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Texas.
Bring specialty, monthly wound volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 14.6% diabetes and 20.1% arthritis for Pasadena — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Pasadena, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Pasadena is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Pasadena — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Pasadena. Useful for joint-program math; still needs a diagnosis and privileging.
No Pasadena storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.